Demiurge Technologies

PharmaceuticalsSeries AZug, Switzerlanddemiurge.technology

Latest round

Series A

Last raised

Nov 2015

Total raised

$7.7M

Investors

1

About Demiurge Technologies

Founded in 2015 and headquartered in Zug, Switzerland, Demiurge Technologies AG specializes in creating virtual patient models that predict clinical trial outcomes.Demiurge Technologies specializes in the development of virtual patient models designed to predict clinical trial outcomes across various therapeutic areas, including oncology, cardiovascular, and infectious diseases. Their core product offerings include advanced predictive modeling for phase 2 and phase 3 clinical trials, which utilize a database of clinical data to construct virtual patients that are clinically equivalent to human subjects. The company released a COVID-19 virtual patient model just six weeks following the World Health Organization's confirmation of human-to-human transmission of SARS-CoV-2.Demiurge Technologies generates revenue through partnerships with pharmaceutical and biotech companies, leveraging their predictive modeling capabilities in a B2B transaction structure. Clients engage with Demiurge to utilize their virtual patient models, which facilitate data-driven decision-making in clinical trials. The company’s flagship service is the provision of predictions for clinical trial outcomes, optimizing client investment and research efforts.Demiurge Technologies plans to enhance its offerings by designing new virtual patient models for emerging therapeutic areas. Additionally, the company aims to expand its geographic presence, targeting markets in North America and Europe by 2026.

Who invested in Demiurge Technologies

1 investor across 1 round

See all investors in Demiurge Technologies

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 1, 2015

    Amount

    $7.7M

    Investors

    Locked

Questions about Demiurge Technologies

Who invested in Demiurge Technologies?

Demiurge Technologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Demiurge Technologies raised?

Demiurge Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Demiurge Technologies last raise money?

Demiurge Technologies's most recent round on record is a Series A, in Nov 2015.

What does Demiurge Technologies do?

Founded in 2015 and headquartered in Zug, Switzerland, Demiurge Technologies AG specializes in creating virtual patient models that predict clinical trial outcomes.

Where is Demiurge Technologies headquartered?

Demiurge Technologies is headquartered in Zug, Switzerland.

Which VCs invest in companies like Demiurge Technologies?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Demiurge Technologies's stage. Their profiles are linked below.

Raising like Demiurge Technologies? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.